Protagonist Therapeutics Inc. (PTGX): Advancing Treatments for Autoimmune Diseases

Yahoo FinanceOct 18 18:28

State Street Corp's Strategic Acquisition in Protagonist Therapeutics Inc

Yahoo FinanceOct 17 03:03

TD Cowen Maintains Protagonist Therapeutics(PTGX.US) With Buy Rating, Maintains Target Price $65

Futu NewsOct 14 20:31 · Ratings

Capitulation in Biotech Is Near, as Well as a Rally – Piper Sandler

Seeking AlphaOct 11 23:17

Truist Financial Maintains Protagonist Therapeutics(PTGX.US) With Buy Rating

Futu NewsOct 7 20:31 · Ratings

Truist Financial Issues a Buy Rating on Protagonist Therapeutics (PTGX)

TipRanksOct 7 19:46 · Ratings